Literature DB >> 7692022

Neurodevelopmental outcome and respiratory morbidity for extracorporeal membrane oxygenation survivors at 1 year of age.

H Flusser1, N N Dodge, W E Engle, B P Garg, K W West.   

Abstract

Outcome at 1 year was evaluated in 37 neonates treated with extracorporeal membrane oxygenation (ECMO) between June 1987 and March 1989. Thirty of 37 survived, and 7 of 30 showed major abnormalities in respiratory status, neurologic examination, or developmental status. Abnormal respiratory status was defined as need for supplemental oxygen, tracheostomy, or mechanical ventilation, and developmental delay was defined as developmental quotient < 70 on either the Mental or Psychomotor scale of the Bayley Scales of Infant Development. Five of seven children with major abnormalities were affected in more than one system. Adverse outcome was associated with the presence of congenital anomalies. Perinatal factors including Apgar scores, last pH before starting extracorporeal membrane oxygenation, and number of hours on ECMO did not show a significant correlation with Bayley scores. Computed tomography and electroencephalography of neonates showed no relationship to Bayley scores or neurologic examination. In conclusion, a small subgroup of patients accounts for the majority of abnormal findings at 1 year, and the presence of congenital anomalies appears to increase the risk for abnormal outcome.

Entities:  

Mesh:

Year:  1993        PMID: 7692022

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Plasma lactate as a predictor of early childhood neurodevelopmental outcome of neonates with severe hypoxaemia requiring extracorporeal membrane oxygenation.

Authors:  P Y Cheung; C M Robertson; N N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

2.  Neurodevelopmental outcome after neonatal extracorporeal membrane oxygenation.

Authors:  C M Robertson; N N Finer; R S Sauve; M F Whitfield; T K Belgaumkar; A R Synnes; M G Grace
Journal:  CMAJ       Date:  1995-06-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.